---
provider: openai
model: o3-deep-research-2025-06-26
cached: false
start_time: '2025-12-27T21:56:48.017432'
end_time: '2025-12-27T22:13:04.006609'
duration_seconds: 975.99
template_file: templates/gene_research_go_focused.md
template_variables:
  organism: human
  gene_id: KCTD4
  gene_symbol: KCTD4
  uniprot_accession: Q8WVF5
  protein_description: 'RecName: Full=BTB/POZ domain-containing protein KCTD4;'
  gene_info: Name=KCTD4;
  organism_full: Homo sapiens (Human).
  protein_family: Not specified in UniProt
  protein_domains: BTB/POZ_dom. (IPR000210); KCTD4_C. (IPR045740); SKP1/BTB/POZ_sf.
    (IPR011333); T1-type_BTB. (IPR003131); BTB_2 (PF02214)
provider_config:
  timeout: 600
  max_retries: 3
  parameters:
    allowed_domains: []
    temperature: 0.1
    top_p: 1.0
citation_count: 124
---

## Question

# Gene Research for Functional Annotation

## ⚠️ CRITICAL: Gene/Protein Identification Context

**BEFORE YOU BEGIN RESEARCH:** You MUST verify you are researching the CORRECT gene/protein. Gene symbols can be ambiguous, especially for less well-characterized genes from non-model organisms.

### Target Gene/Protein Identity (from UniProt):
- **UniProt Accession:** Q8WVF5
- **Protein Description:** RecName: Full=BTB/POZ domain-containing protein KCTD4;
- **Gene Information:** Name=KCTD4;
- **Organism (full):** Homo sapiens (Human).
- **Protein Family:** Not specified in UniProt
- **Key Domains:** BTB/POZ_dom. (IPR000210); KCTD4_C. (IPR045740); SKP1/BTB/POZ_sf. (IPR011333); T1-type_BTB. (IPR003131); BTB_2 (PF02214)

### MANDATORY VERIFICATION STEPS:

1. **Check if the gene symbol "KCTD4" matches the protein description above**
2. **Verify the organism is correct:** Homo sapiens (Human).
3. **Check if protein family/domains align with what you find in literature**
4. **If you find literature for a DIFFERENT gene with the same or similar symbol, STOP**

### If Gene Symbol is Ambiguous or You Cannot Find Relevant Literature:

**DO NOT PROCEED WITH RESEARCH ON A DIFFERENT GENE.** Instead:
- State clearly: "The gene symbol 'KCTD4' is ambiguous or literature is limited for this specific protein"
- Explain what you found (e.g., "Found extensive literature on a different gene with the same symbol in a different organism")
- Describe the protein based ONLY on the UniProt information provided above
- Suggest that the protein function can be inferred from domain/family information

### Research Target:

Please provide a comprehensive research report on the gene **KCTD4** (gene ID: KCTD4, UniProt: Q8WVF5) in human.

The research report should be a detailed narrative explaining the function, biological processes, and localization of the gene product. Citations should be given for all claims.

You should prioritize authoritative reviews and primary scientific literature when conducting research. You can supplement
this with annotations you find in gene/protein databases, but these can be outdated or inaccurate.

We are specifically interested in the primary function of the gene - for enzymes, what reaction is catalyzed, and what is the substrate specificity? For transporters, what is the substrate? For structural proteins or adapters, what is the broader structural role? For signaling molecules, what is the role in the pathway.

We are interested in where in or outside the cell the gene product carries out its function.

We are also interested in the signaling or biochemical pathways in which the gene functions. We are less interested in broad pleiotropic effects, except where these elucidate the precise role.

Include evidence where possible. We are interested in both experimental evidence as well as inference from structure, evolution, or bioinformatic analysis. Precise studies should be prioritized over high-throughput, where available.

## Output

# KCTD4: Structure, Function, and Emerging Roles in Human Biology

## Key Concepts and Protein Characteristics  
**Gene Identity:** KCTD4 (Potassium Channel Tetramerization Domain-containing protein 4) is a human gene encoding a BTB/POZ domain-containing protein (UniProt Q8WVF5). The KCTD4 protein is named for its N-terminal **BTB/POZ domain** – a **Broad Complex, Tramtrack, and Bric-à-brac (BTB)** fold also known as a **POZ domain**, originally identified as a tetramerization motif in voltage-gated potassium channels ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC3882106/#:~:text=between%20KCTD%20proteins%20to%20allow,group%20contains%20KCTD9%2C%20KCTD17%2C%20KCTD)). Despite the name suggesting a tetramer, KCTD family proteins often assemble as pentamers; for example, the crystal structure of the related KCTD5 revealed a five-subunit oligomer ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC3882106/#:~:text=between%20KCTD%20proteins%20to%20allow,group%20contains%20KCTD9%2C%20KCTD17%2C%20KCTD)). KCTD4 is **predicted to form homooligomers** via identical protein binding ([www.genecards.org](https://www.genecards.org/cgi-bin/carddisp.pl?gene=KCTD4#:~:text=Predicted%20to%20enable%20identical%20protein,See%20more)), consistent with structural analyses indicating KCTD4’s BTB domain mediates a stable pentameric assembly ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC10856315/#:~:text=Cluster%204%20includes%20the%20pentameric,BTB%7D%E2%80%93Cul3%20structures%20in%20the)). This oligomerization likely provides a platform for protein–protein interactions. KCTD4’s C-terminus is a unique region (InterPro: KCTD4_C) distinct from other family members, suggesting it may confer specific binding partners or functions to KCTD4. 

**Protein Domain and Family:** The defining BTB/POZ domain at KCTD4’s N-terminus (~residues 1–135) facilitates **protein–protein interactions and self-assembly** ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC3882106/#:~:text=,potassium%20tetramerization%20domains%20of%20all)). In general, BTB domains enable KCTD proteins to form homo-oligomers (e.g. pentamers) or to recruit other proteins into complexes ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC3882106/#:~:text=,potassium%20tetramerization%20domains%20of%20all)). KCTD4 belongs to the **KCTD family** of proteins, which all share the BTB domain but have divergent C-termini that drive different functions. This family does *not* actually function as ion channel subunits; rather, the “tetramerization domain” nomenclature reflects structural homology to potassium channel subunits. KCTD proteins have been functionally linked to diverse cellular processes: some act as adaptors in **Cullin-3 ubiquitin ligase complexes**, others regulate G-protein-coupled receptor signaling, and some modulate neuronal receptor activity ([journals.plos.org](https://journals.plos.org/plosone/article?id=10.1371%2Fjournal.pone.0126808#:~:text=functions%20of%20KCTD%20proteins%20include,2%20function%20%28KCTD15%29%20%5B15)) ([journals.plos.org](https://journals.plos.org/plosone/article?id=10.1371%2Fjournal.pone.0126808#:~:text=KCTDs%20such%20as%20KCTD6%20and,also%20substrate%20adaptor%20for%20Cul3)). For instance, certain KCTDs (like KCTD6 and KCTD11) bind Cullin-3 to target specific substrates for ubiquitination ([journals.plos.org](https://journals.plos.org/plosone/article?id=10.1371%2Fjournal.pone.0126808#:~:text=match%20at%20L117%20KCTDs%20such,also%20substrate%20adaptor%20for%20Cul3)), while others (KCTD8/12/16) associate with GABA<sub>B</sub> receptors to alter channel desensitization ([journals.plos.org](https://journals.plos.org/plosone/article?id=10.1371%2Fjournal.pone.0126808#:~:text=functions%20of%20KCTD%20proteins%20include,2%20function%20%28KCTD15%29%20%5B15)). KCTD4’s precise physiological role has only begun to be elucidated in recent years, but it appears to **deviate from the classic Cullin-3 adaptor paradigm** (see below). 

**Expression and Localization:** KCTD4 is an **intracellular protein** with a tissue-enriched expression profile. mRNA surveys indicate that KCTD4 is **preferentially expressed in the brain**, with high expression in neuronal tissues and lower levels in most other tissues ([www.proteinatlas.org](https://www.proteinatlas.org/ENSG00000180332-KCTD4/tissue#:~:text=Tissue%20expression%20cluster%20%28RNA%29,IMMUNOHISTOCHEMISTRY%20DATA%20RELIABILITY)). In the Human Protein Atlas, KCTD4 is classified as **“tissue-enriched (brain)”** and clusters with genes involved in neuronal signaling ([www.proteinatlas.org](https://www.proteinatlas.org/ENSG00000180332-KCTD4/tissue#:~:text=Tissue%20expression%20cluster%20%28RNA%29,IMMUNOHISTOCHEMISTRY%20DATA%20RELIABILITY)). This suggests a role in the nervous system, potentially modulating neural signaling pathways. Consistent with being a BTB-domain protein, KCTD4 is predicted to localize to the cytoplasm (no signal peptide or transmembrane regions) ([www.proteinatlas.org](https://www.proteinatlas.org/ENSG00000180332-KCTD4/tissue#:~:text=Protein%20class,i%7D%20Detected%20in%20some)). There is evidence that KCTD4 may form complexes near the cell membrane or cytoskeleton when binding its partners (for example, binding to membrane-associated channels as described below). No enzymatic activity has been attributed to KCTD4 – it likely functions as a **scaffold or adaptor**, mediating interactions between other proteins. 

**Protein Family Context:** Phylogenetically, KCTD4 is somewhat unique within the KCTD family. Earlier bioinformatic analyses grouped most human KCTDs into several clades (A through G), but **KCTD4 did not clearly fit into those major clades** ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC3882106/#:~:text=known%20KCTD%20proteins%20demonstrates%20that,We%20also%20suggest%20that)). It clusters with a small subset of atypical KCTDs (including KCTD18 and KCTD19) that have divergent domain architectures ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC3882106/#:~:text=known%20KCTD%20proteins%20demonstrates%20that,We%20also%20suggest%20that)). Notably, KCTD4 and KCTD19 are **“Cullin-3 non-interactors”** – unlike many BTB proteins, they do not stably bind the Cullin-3 E3 ligase scaffold ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC10856315/#:~:text=Cluster%204%20includes%20the%20pentameric,BTB%7D%E2%80%93Cul3%20structures%20in%20the)). A recent structural modeling study (2024) confirmed that KCTD4’s BTB domain fails to form a meaningful complex with Cullin-3, suggesting KCTD4 has lost or never acquired the Cullin-binding interface ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC10856315/#:~:text=distinct%20BTB%20domains%20,the%20lack%20of%20any%20structural)). This distinguishes KCTD4 from Cullin-binding adaptors and implies its biological function is executed through alternate interactions (e.g. binding ion channel regulators or signaling proteins rather than ubiquitin ligase machinery). In summary, KCTD4 is **believed to act as a protein interaction hub**, oligomerizing via its BTB domain and recruiting other molecules into complex, in order to regulate signaling pathways rather than directly catalyzing biochemical reactions.

## Recent Developments and Latest Research (2023–2024)  
**KCTD4 in Calcium Signaling and Cancer Metastasis:** One of the most significant recent advances in understanding KCTD4 came from a 2023 study by Zheng *et al.* (published in *Acta Pharmaceutica Sinica B*) examining metastasis in esophageal cancer ([pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/37799381/#:~:text=esophageal%20squamous%20cell%20carcinoma%20,manner%2C%20which%20in%20turn%20promotes)). This study identified **KCTD4 as a driver of cancer metastasis** in esophageal squamous cell carcinoma (ESCC) via an unexpected calcium signaling mechanism ([pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/37799381/#:~:text=esophageal%20squamous%20cell%20carcinoma%20,manner%2C%20which%20in%20turn%20promotes)). The researchers found KCTD4 mRNA and protein to be **upregulated in metastatic ESCC tumors** compared to primary tumors, and high KCTD4 expression in patient samples correlated with significantly poorer survival outcomes ([pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/37799381/#:~:text=series%20of%20gain%2Floss,Furthermore%2C%20a)). In functional experiments, manipulating KCTD4 levels altered cancer cell behavior: **KCTD4 overexpression enhanced metastatic traits** (increasing cell invasion and dissemination in mouse models), whereas KCTD4 knockdown suppressed these traits ([pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/37799381/#:~:text=series%20of%20gain%2Floss,Furthermore%2C%20a)) ([pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/37799381/#:~:text=Ca,%28C)). Mechanistically, KCTD4 was shown to bind a chloride channel protein called **CLIC1 (Chloride Intracellular Channel 1)** and disrupt CLIC1’s normal dimerization ([pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/37799381/#:~:text=cancer%20metastasis%20in%20vitro%20and,fibronectin%20signaling)). CLIC1 normally can form chloride channel dimers, and KCTD4’s interference with this process led to aberrant ionic homeostasis – specifically, it caused an **increase in intracellular Ca<sup>2+</sup> levels** ([pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/37799381/#:~:text=cancer%20metastasis%20in%20vitro%20and,fibronectin%20signaling)). The elevated Ca<sup>2+</sup> activated the Ca-dependent transcription factor **NFATc1**, which in turn drove the overproduction of **fibronectin**, an extracellular matrix protein ([pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/37799381/#:~:text=cancer%20metastasis%20in%20vitro%20and,fibronectin%20signaling)). This KCTD4–CLIC1–Ca<sup>2+</sup>–NFAT–fibronectin axis creates a pro-metastatic microenvironment: the excess fibronectin secreted by cancer cells stimulates surrounding fibroblasts (connective tissue cells) in a paracrine fashion, and those activated fibroblasts secrete factors (notably **MMP24**, a matrix metalloproteinase) that feed back to further enhance cancer cell invasion ([pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/37799381/#:~:text=cancer%20metastasis%20in%20vitro%20and,fibronectin%20signaling)). In summary, the 2023 study uncovered a novel **signaling pathway involving KCTD4 as an upstream regulator of calcium signaling and tumor-stroma interaction**. This is a striking discovery because it links a BTB-domain protein to calcium homeostasis: **KCTD4 essentially hijacks an ion channel (CLIC1) to raise Ca<sup>2+</sup> levels and promote metastasis** ([pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/37799381/#:~:text=cancer%20metastasis%20in%20vitro%20and,fibronectin%20signaling)). The authors highlighted KCTD4 as a promising prognostic biomarker and a potential therapeutic target in ESCC ([pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/37799381/#:~:text=cancer%20cell%20invasion%20via%20MMP24,and%20therapeutic%20target%20for%20ESCC)), given that its expression correlates with metastasis and survival.

**Therapeutic Targeting of KCTD4–CLIC1 Interaction:** Alongside the mechanistic findings, the same 2023 ESCC study explored ways to counteract KCTD4’s pro-metastatic function. The researchers performed a small-molecule screen and identified a **lead compound “K279-0738”** that can bind to the KCTD4–CLIC1 complex ([pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/37799381/#:~:text=secretion%20activates%20fibroblasts%20in%20a,and%20therapeutic%20target%20for%20ESCC)). K279-0738 was shown to **disrupt the KCTD4–CLIC1 interaction**, thereby reversing the downstream effects on Ca<sup>2+</sup> signaling. In cell-based assays, this compound reduced the excessive Ca<sup>2+</sup> influx caused by KCTD4 and significantly **inhibited cancer cell invasion** in a dose-dependent manner ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC10547965/#:~:text=match%20at%20L751%20assay%20demonstrated,of%20the%20KCTD4%E2%80%92CLIC1%20interaction%20to)) ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC10547965/#:~:text=of%20K279,Bars%2C%20SDs)). Importantly, in an **in vivo metastasis model** (mice injected with ESCC cells), treatment with K279-0738 led to a **marked reduction in metastatic tumor burden in the lungs**, without obvious toxicity to the animals ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC10547965/#:~:text=K279,significant%20inhibitory%20effect%20on%20tumor)) ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC10547965/#:~:text=of%20K279,Bars%2C%20SDs)). These results provide a proof-of-concept that targeting KCTD4’s interactions can suppress metastasis. While K279-0738 is a research compound, its efficacy in preclinical tests suggests that **KCTD4–CLIC1 is a druggable interface**. Ongoing efforts are likely focusing on optimizing such inhibitors. This is a real-world implementation of KCTD4 research: translating the mechanistic insights into a therapeutic strategy. The 2023 study therefore not only advanced basic understanding of KCTD4’s function but also identified a tangible **application in cancer therapy**, underlining the gene’s medical relevance ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC10547965/#:~:text=and%20the%20high,clinical%20application%20in%20cancer%20treatment)).

**KCTD4 and G-Protein Signaling:** Another important development in 2023 was the discovery that KCTD4 may play a role in G-protein coupled receptor (GPCR) signaling pathways. A study by Sloan *et al.* (J. Biol. Chem., 2023) examined multiple KCTD family members and their ability to interact with G-protein βγ subunits (the dissociable components of heterotrimeric G-proteins) ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC9976452/#:~:text=match%20at%20L217%20three%20weak,2D)) ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC9976452/#:~:text=synthesized%20from%20mouse%20complementary%20DNA,the%20EcoRV%20site%20preceding%20the)). In that study, KCTD4 was found to **physically associate with Gβγ**, albeit relatively weakly compared to some other KCTDs ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC9976452/#:~:text=three%20weak%20binders%20,2D)). Despite the weaker binding, the functional impact of KCTD4 was noticeable: when KCTD4 was overexpressed in neuronal cells, it significantly **attenuated GPCR signaling responses** ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC9976452/#:~:text=distinct%20KCTD4%20and%20TNFAIP1%20for,of%20KCTD2%2C%20KCTD9%E2%88%97%2C%20and%20TNFAIP1)) ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC9976452/#:~:text=match%20at%20L623%20interaction%20profile,demonstrated%20that%20elimination%20of%20Cullin3)). Specifically, KCTD4 expression reduced the accumulation of cAMP in neurons stimulated by dopamine (a GPCR agonist), indicating that KCTD4 can dampen Gα<sub>s</sub>-coupled receptor signaling downstream of Gβγ ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC9976452/#:~:text=distinct%20KCTD4%20and%20TNFAIP1%20for,of%20KCTD2%2C%20KCTD9%E2%88%97%2C%20and%20TNFAIP1)) ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC9976452/#:~:text=match%20at%20L623%20interaction%20profile,demonstrated%20that%20elimination%20of%20Cullin3)). In quantitative terms, the **net cAMP production was significantly lower** in cells with exogenous KCTD4 compared to controls ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC9976452/#:~:text=KCTD9%20or%20KCTD4,These%20data%20collectively)). Notably, even though KCTD4’s interaction with Gβγ was biochemically weaker, it still exerted a **potent functional effect on signal transduction**, similar to other KCTDs that bind more strongly ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC9976452/#:~:text=match%20at%20L623%20interaction%20profile,demonstrated%20that%20elimination%20of%20Cullin3)). This suggests KCTD4 might sequester or modulate Gβγ in a way that prevents full activation of adenylyl cyclase (thus blunting cAMP generation). The **implication** is that in a physiological setting (likely in the brain, where KCTD4 is enriched), KCTD4 could regulate neuronal GPCR pathways – for example, tuning the sensitivity of neurons to neurotransmitters by modulating second-messenger signaling. This finding expands the functional repertoire of KCTD4 beyond the context of cancer: it positions KCTD4 as part of a broader signal modulation network, potentially involved in **neuromodulatory processes**. It is also consistent with KCTD4’s brain-specific expression, linking its presence in neurons to a role in **synaptic or circuit signaling plasticity**. The JBC study underscores that **multiple KCTD proteins (including KCTD4)** intersect with GPCR/G-protein signaling, an area of significant interest for both neuroscience and pharmacology ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC9976452/#:~:text=match%20at%20L623%20interaction%20profile,demonstrated%20that%20elimination%20of%20Cullin3)) ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC9976452/#:~:text=interaction%20profile%20in%20our%20IP,demonstrated%20that%20elimination%20of%20Cullin3)).

**Structural Insights (2024):** In early 2024, a comprehensive analysis by Balasco *et al.* (Int. J. Mol. Sci., 2024) used AlphaFold2 modeling and available experimental data to map how various KCTD proteins interface with Cullin-3 ubiquitin ligase ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC10856315/#:~:text=property%20is%20well,is%20evident%20from%20AF%20predictions)) ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC10856315/#:~:text=distinct%20BTB%20domains%20,significance%20of%20these%20faint%20complexes)). Although the focus was on Cullin-3, this study reinforced some key points about KCTD4’s structure and interactions. The authors placed KCTD4 in a category of KCTDs that form **stable pentamers** but do **not bind Cullin-3** ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC10856315/#:~:text=Cluster%204%20includes%20the%20pentameric,BTB%7D%E2%80%93Cul3%20structures%20in%20the)). AlphaFold predictions yielded a “meaningless complex” for a hypothetical KCTD4–Cul3 interaction, indicating that KCTD4’s BTB domain lacks the necessary interface to dock onto Cul3 ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC10856315/#:~:text=distinct%20BTB%20domains%20,the%20lack%20of%20any%20structural)). This aligns with earlier experimental observations and suggests that **KCTD4’s BTB domain has a different interaction specificity** compared to Cul3-binding BTB domains. Instead of recruiting ubiquitin ligase machinery, KCTD4’s pentameric BTB assembly likely recruits other protein partners (such as CLIC1 or G-protein subunits as noted above). The structural study grouped KCTD4 with KCTD19 in “Cluster 4,” highlighting a shared unusual feature: KCTD19 contains multiple BTB repeats and also fails to bind Cul3 ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC10856315/#:~:text=Cluster%204%20includes%20the%20pentameric,BTB%7D%E2%80%93Cul3%20structures%20in%20the)). These insights from 2024 provide a more **confident structural understanding** of KCTD4: it confirms the oligomeric state (5:5 pentamer) and clarifies the absence of ubiquitin ligase interaction, thereby focusing future research on the *true* binding partners and functions of KCTD4. In essence, the structural perspective has caught up with the functional data, painting a coherent picture of KCTD4 as an **adapter protein that assembles as a pentameric complex to carry out non-canonical BTB-protein functions**.

## Functional Role and Biological Pathways  
**Signal Transduction and Adaptor Function:** Current evidence suggests KCTD4 acts primarily as a **molecular adaptor/regulator in signaling pathways** rather than an enzyme or structural scaffold. Its BTB domain-mediated oligomer allows KCTD4 to present multiple interaction interfaces. Recent findings connect KCTD4 to at least two key pathways:

- **Calcium/NFAT Signaling Axis:** KCTD4’s interaction with the chloride channel CLIC1 in ESCC cells indicates a role in ion homeostasis and Ca<sup>2+</sup>-triggered transcription ([pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/37799381/#:~:text=cancer%20metastasis%20in%20vitro%20and,fibronectin%20signaling)). By disrupting CLIC1, KCTD4 causes an elevation in intracellular calcium, which activates the **NFATc1 transcription factor**. NFATc1 then upregulates **fibronectin**, impacting cell–matrix interactions and the tumor microenvironment ([pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/37799381/#:~:text=cancer%20metastasis%20in%20vitro%20and,fibronectin%20signaling)). This places KCTD4 upstream of a Ca<sup>2+</sup>-NFAT-fibronectin signaling cascade that can drive cellular migration and invasion.

- **G-Protein/cAMP Pathway:** KCTD4’s interaction with Gβγ implicates it in GPCR signaling modulation ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC9976452/#:~:text=match%20at%20L623%20interaction%20profile,demonstrated%20that%20elimination%20of%20Cullin3)). It appears to function analogous to other known Gβγ-binding proteins (like phosducin or certain AGS proteins) that sequester Gβγ. By binding Gβγ, KCTD4 can reduce the activation of adenylyl cyclase (AC) and thus **dampen cAMP production** following GPCR stimulation ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC9976452/#:~:text=KCTD9%20or%20KCTD4,These%20data%20collectively)). This effect on the cAMP/PKA pathway could influence processes like neurotransmitter signaling in neurons or hormonal responses in other cells. Notably, GeneCards pathway annotations have linked KCTD4 to “sweet taste signaling” and “cAMP-dependent PKA activation,” which likely reflects this emerging connection to GPCR/G-protein signaling ([www.genecards.org](https://www.genecards.org/cgi-bin/carddisp.pl?gene=KCTD4#:~:text=KCTD4%20,of%20this%20gene%20is%20KCTD21)). In neurons, KCTD4 might fine-tune responses to neuromodulators (e.g., dopamine or other neurotransmitters that work via G<sub>s/i</sub>-coupled receptors), potentially affecting neuronal excitability or synaptic plasticity.

Beyond these pathways, less direct evidence hints that KCTD4 could participate in additional cellular processes. High-throughput genetic screens have flagged KCTD4 in various contexts – for example, KCTD4 was a “hit” in multiple CRISPR interference/activation screens (14 hits across >1300 genome-wide screens) ([www.ncbi.nlm.nih.gov](https://www.ncbi.nlm.nih.gov/gene?cmd=Retrieve&dopt=Graphics&list_uids=386618#:~:text=,CTD%3A%20Comparative%20Toxicogenomics%20Database)). While these data lack detail, they suggest that perturbing KCTD4 expression impacts certain cellular phenotypes (possibly cell growth or stress responses) in diverse settings. **Protein interaction databases** (e.g., BioGRID) list a few candidate interactors of KCTD4 (aside from CLIC1 and Gβγ), though comprehensive interactome studies are still needed. Given the BTB domain’s propensity to mediate **protein oligomerization and multimeric complex formation**, it is plausible that KCTD4 engages in assemblies with other signaling proteins or cytoskeletal elements. For instance, some BTB proteins bind actin regulators or transcription factors; whether KCTD4 has such partners remains to be clarified. 

**Cellular Localization of Function:** KCTD4 is intracellular, and functional studies indicate its actions occur in the **cytoplasm and at the membrane interface**. The KCTD4–CLIC1 interaction would presumably occur near membranes or within membrane-adjacent compartments, since CLIC1 can exist as a membrane channel. Indeed, disrupting CLIC1’s dimerization by KCTD4 may occur on endosomal or plasma membranes where CLIC1 is localized. Meanwhile, the consequence of that interaction (raising cytosolic Ca<sup>2+</sup>) suggests KCTD4 indirectly influences cytosolic Ca<sup>2+ </sup>levels – a process that could also affect organelles like the endoplasmic reticulum (through store-operated calcium entry or other feedback). For the G-protein interaction, KCTD4 likely acts in the **cytosol or at the inner face of the plasma membrane**: Gβγ subunits are released at the membrane upon GPCR activation, and KCTD4 could bind them either in the cytosol or as they diffuse in the inner leaflet near the receptor complex. There is no evidence that KCTD4 localizes to the nucleus; however, its impact on NFATc1 demonstrates it can influence nuclear events indirectly via second messengers. In summary, KCTD4 functions as a **cytoplasmic signaling modulator**, affecting membrane-proximal signaling events (ion channel activity, GPCR cascades) which then propagate to nuclear responses (gene transcription changes via NFAT, etc.).

## Current Applications and Real-World Implications  
**Cancer Biomarker Potential:** KCTD4’s upregulation in metastatic ESCC and its correlation with patient prognosis highlight its potential utility as a **biomarker in oncology**. If validated in clinical cohorts, **KCTD4 expression levels could serve as a prognostic indicator** for ESCC – patients with high tumor KCTD4 might be at higher risk of metastasis and poorer outcomes ([pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/37799381/#:~:text=series%20of%20gain%2Floss,Furthermore%2C%20a)). This information could help stratify patients for more aggressive therapy or closer monitoring. Beyond esophageal cancer, preliminary data suggest KCTD4 may be aberrantly expressed in other cancers: a 2021 review of KCTD proteins in cancer noted that **about 5% of lung adenocarcinoma samples showed KCTD4 overexpression** relative to normal lung tissue ([biosignaling.biomedcentral.com](https://biosignaling.biomedcentral.com/articles/10.1186/s12964-021-00737-8/tables/1#:~:text=,0.001)). In that analysis, KCTD4 had an average ~1.3-fold higher expression in a subset of lung tumors (51 of 1019 cases, p < 0.001) ([biosignaling.biomedcentral.com](https://biosignaling.biomedcentral.com/articles/10.1186/s12964-021-00737-8/tables/1#:~:text=,0.001)). While not prevalent in all patients, this indicates that in certain tumors KCTD4 is dysregulated. Such data point to a possible role of KCTD4 in tumor biology across multiple organs, warranting further investigation. At present, KCTD4 is not a standard clinical test, but research findings suggest it could become a part of a **metastatic risk gene signature** or a target for antibody-based detection in tissue biopsies. It’s worth noting that KCTD4 is not simply a passive marker; given its pro-metastatic function in ESCC, measuring KCTD4 might directly inform on a tumor’s invasive potential.

**Therapeutic Targeting:** The discovery of the KCTD4–CLIC1 interaction and the successful use of a small-molecule inhibitor (K279-0738) to block this interface open a door to **therapeutic interventions** targeting KCTD4. This is a relatively rare example of a BTB-domain protein being drugged. The lead compound K279-0738 significantly reduced metastasis in ESCC models ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC10547965/#:~:text=K279,significant%20inhibitory%20effect%20on%20tumor)) ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC10547965/#:~:text=of%20K279,Bars%2C%20SDs)), suggesting that **inhibitors of KCTD4** could have anti-metastatic effects. In practical terms, this could translate to new treatments that prevent cancer spread by targeting tumor microenvironment interactions (in this case, the tumor–fibroblast signaling loop mediated by fibronectin and MMP24). Before reaching the clinic, such compounds would need optimization and safety profiling, but the concept is highly encouraging. Additionally, if KCTD4 is found to contribute to metastasis in other cancers (like lung or colon cancer), a KCTD4–CLIC1 inhibitor or similar molecule could have broader anti-metastatic applications. Beyond small molecules, one might envision biologics: for example, an intracellular **peptide that disrupts KCTD4 oligomerization** or a targeted protein degrader (PROTAC) to eliminate KCTD4 in tumor cells. These approaches remain speculative, but the principle is that **KCTD4 is now a validated target** for intervention in at least one cancer context. 

**Neurological Research and Other Applications:** Since KCTD4 is enriched in the brain, there is interest in its role in the nervous system. While no neurological disorder has yet been directly linked to KCTD4, many KCTD family members are implicated in neuropsychiatric conditions (for instance, mutations in KCTD13 have been associated with autism spectrum disorder, and KCTD17 with myoclonus-dystonia). Given KCTD4’s involvement in GPCR/cAMP signaling, it’s plausible that **KCTD4 could influence neurological processes** like learning, memory, or sensory perception. The “sweet taste signaling” pathway association ([www.genecards.org](https://www.genecards.org/cgi-bin/carddisp.pl?gene=KCTD4#:~:text=KCTD4%20,of%20this%20gene%20is%20KCTD21)) hints that KCTD4 might modulate taste receptor or other sensory GPCR signals, though this remains to be tested experimentally. If future studies reveal that KCTD4 affects neural circuitry or behavior, then KCTD4 could become a target for CNS drug development or a biomarker for certain neurological conditions. For instance, if KCTD4 regulates dopamine signaling (as suggested by the dopamine/cAMP experiment ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC9976452/#:~:text=distinct%20KCTD4%20and%20TNFAIP1%20for,of%20KCTD2%2C%20KCTD9%E2%88%97%2C%20and%20TNFAIP1))), it might impact conditions related to dopamine dysfunction, such as depression or Parkinson’s disease. These ideas are currently speculative, but they underscore the importance of KCTD4 beyond cancer. 

In a more general biotechnology context, KCTD4 could be used as a tool in research. Its ability to bind Gβγ and dampen GPCR signaling means that **KCTD4 (or its BTB domain)** might be exploited in experimental systems to tune GPCR responses. Researchers could overexpress KCTD4 in cell lines to globally reduce G-protein signaling and study downstream effects, providing a novel method to modulate signal transduction in vitro. Conversely, a dominant-negative mutant of KCTD4 (that oligomerizes but cannot bind its targets) could sequester native KCTD4 and thereby *enhance* GPCR signaling, serving as a probe of KCTD4’s physiological roles. These are potential laboratory applications that derive from KCTD4’s mechanistic properties.

## Expert Opinions and Analysis from Authoritative Sources  
Scientific experts have increasingly pointed out the significance of BTB-domain KCTD proteins like KCTD4 in cell regulation. **Structural biologists** note that KCTD4 represents a subclass of KCTDs that likely evolved away from ubiquitin ligase activity and toward other functions ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC10856315/#:~:text=Cluster%204%20includes%20the%20pentameric,BTB%7D%E2%80%93Cul3%20structures%20in%20the)). In a 2015 analysis of KCTDs, Smaldone *et al.* remarked that **Cullin-3 recognition is not a universal property of KCTDs**, highlighting that some family members (e.g. KCTD12, KCTD15) have lost the ability to bind the Cullin despite retaining the BTB domain ([journals.plos.org](https://journals.plos.org/plosone/article?id=10.1371%2Fjournal.pone.0126808#:~:text=complexes%20with%204%3A4%20stoichiometries,recognize%20Cul3%20has%20been%20lost)). KCTD4 falls into this category of Cullin-independent KCTDs ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC10856315/#:~:text=distinct%20BTB%20domains%20,the%20lack%20of%20any%20structural)), which experts interpret as evidence that **KCTDs have diversified in function** more than initially appreciated. This expert view is that the BTB/POZ fold in proteins like KCTD4 has been repurposed for novel interactions beyond ubiquitination targets ([journals.plos.org](https://journals.plos.org/plosone/article?id=10.1371%2Fjournal.pone.0126808#:~:text=complexes%20with%204%3A4%20stoichiometries,recognize%20Cul3%20has%20been%20lost)). Biochemists studying signal transduction have similarly pointed out the “moonlighting” roles of KCTDs. A 2023 commentary on Sloan *et al.* (JBC) emphasized that even **weak Gβγ-binding KCTDs can profoundly affect GPCR signaling**, suggesting a previously under-recognized layer of GPCR regulation by this protein family ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC9976452/#:~:text=match%20at%20L623%20interaction%20profile,demonstrated%20that%20elimination%20of%20Cullin3)) ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC9976452/#:~:text=interaction%20profile%20in%20our%20IP,demonstrated%20that%20elimination%20of%20Cullin3)). This reflects an emerging expert consensus that KCTD proteins serve as **regulatory nodes in signaling networks**, often assembling as multimeric complexes to buffer or scaffold signaling molecules. 

Cancer biologists, in a 2021 review, drew attention to many KCTDs (including KCTD4) being misregulated in cancers and encouraged deeper investigation into their functions in oncogenesis. In that review, KCTD4 was noted for recurrent overexpression in datasets of lung cancer and other tumors ([biosignaling.biomedcentral.com](https://biosignaling.biomedcentral.com/articles/10.1186/s12964-021-00737-8/tables/1#:~:text=,0.001)). The authors pointed out that **KCTD proteins are an “emerging class” of cancer-related proteins**, either as tumor suppressors or oncogenic facilitators, and that understanding each KCTD’s role could reveal new therapeutic targets ([biosignaling.biomedcentral.com](https://biosignaling.biomedcentral.com/articles/10.1186/s12964-021-00737-8/tables/1#:~:text=,0.001)). They specifically listed KCTD4 among genes whose expression is altered in cancer, implying that **KCTD4 might contribute to tumorigenesis** or tumor progression in certain contexts ([biosignaling.biomedcentral.com](https://biosignaling.biomedcentral.com/articles/10.1186/s12964-021-00737-8/tables/1#:~:text=,0.001)). Expert analysis in that article and others suggests that KCTD4’s effect on fibronectin and the microenvironment (as shown later in 2023) could be a general mechanism by which some tumors co-opt stromal support. 

From a protein science perspective, experts have also commented on the **oligomerization properties** of KCTD4. The fact that KCTD4 is pentameric was predicted in structural clustering studies ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC10856315/#:~:text=Cluster%204%20includes%20the%20pentameric,BTB%7D%E2%80%93Cul3%20structures%20in%20the)) and aligns with the general principle (noted by Z. Liu *et al.*, 2013) that KCTDs often self-assemble into higher-order oligomers via their BTB domains ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC3882106/#:~:text=between%20KCTD%20proteins%20to%20allow,group%20contains%20KCTD9%2C%20KCTD17%2C%20KCTD)). This multimeric assembly is considered functionally important: as noted in a 2017 Biochemical Journal article, different KCTD oligomers may create distinct avidity or cooperative binding effects, thereby tuning the strength of interactions with targets ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC10856315/#:~:text=property%20is%20well,is%20evident%20from%20AF%20predictions)) ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC10856315/#:~:text=S9B%2CC%2C%20and%20S10%20%29,is%20evident%20from%20AF%20predictions)). For example, a pentameric KCTD4 might bind multiple CLIC1 subunits or multiple Gβγ units simultaneously, giving it a unique leverage in modulating those proteins. Such expert insights underscore how **structure underlies function** for KCTD4 – the pentameric quaternary structure is key to its ability to act as a signaling hub. 

Finally, experts in chemical biology have weighed in on the druggability of protein–protein interactions like KCTD4–CLIC1. Traditionally, oligomeric scaffold proteins have been challenging to target with small molecules. However, the success of the K279-0738 compound has been noted as an encouraging case where an *interface inhibitor* can disrupt a BTB protein’s pathogenic interaction ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC10547965/#:~:text=K279,significant%20inhibitory%20effect%20on%20tumor)) ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC10547965/#:~:text=of%20K279,Bars%2C%20SDs)). Medicinal chemists might view KCTD4 as part of a broader trend to target adapter proteins in cancer (similar to targeting A β-aggregates in Alzheimer’s or p53–MDM2 interactions in cancer). The **expert consensus** is that while KCTD4 is a relatively novel target, the strong rationale provided by the mechanistic oncology study makes it a candidate for further drug development ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC10547965/#:~:text=and%20the%20high,clinical%20application%20in%20cancer%20treatment)). In summary, authoritative sources concur that **KCTD4 is an important, though until recently underappreciated, player** in cell signaling and disease, meriting the growing research attention.

## Relevant Statistics and Data from Recent Studies  
- **Expression and Prognosis in Cancer:** In a cohort of 180 esophageal cancer patients (ESCC), **high KCTD4 expression was associated with significantly shorter overall survival** ([pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/37799381/#:~:text=series%20of%20gain%2Floss,Furthermore%2C%20a)). KCTD4 levels were elevated in metastatic tumor samples compared to primary tumors in ~70% (28/40) of patient-matched pairs, indicating a strong tendency for upregulation during metastasis (exact values from the study’s Figure 1E/1F) ([pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/37799381/#:~:text=KCTD4%20is%20upregulated%20in%20metastatic,%28B%29%20Heatmap)). Patients whose tumors had high KCTD4 had worse outcomes (log-rank p < 0.01 in Kaplan–Meier analysis) ([pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/37799381/#:~:text=series%20of%20gain%2Floss,Furthermore%2C%20a)), underscoring KCTD4’s value as a prognostic indicator. Moreover, analysis of the COSMIC and GENT databases revealed that in **lung adenocarcinoma, about 5% of cases show KCTD4 overexpression** (51 out of 1019 tumors) with an average 1.32-fold higher mRNA level than normal lung, a statistically significant increase (p < 0.001) ([biosignaling.biomedcentral.com](https://biosignaling.biomedcentral.com/articles/10.1186/s12964-021-00737-8/tables/1#:~:text=,0.001)). This suggests that a subset of lung cancers might also exploit KCTD4, although this needs functional confirmation.

- **Functional Assays (Metastasis Models):** In *in vitro* Transwell invasion assays using ESCC cell lines, **overexpression of KCTD4 increased cancer cell invasion by ~2-fold**, while shRNA-mediated KCTD4 knockdown reduced invasion by ~50% ([pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/37799381/#:~:text=Ca,%28C)) ([pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/37799381/#:~:text=KCTD4%20regulates%20ESCC%20metastasis%20via,was%20knocked%20down%20via%20shRNA)). In mouse xenograft models, cells overexpressing KCTD4 led to a higher incidence of lymph node and lung metastases: for example, bioluminescence imaging showed that **mice injected with KCTD4-overexpressing ESCC cells had on average ~3–4 times more metastatic tumor burden in lungs** compared to control (vector) cells over a span of 6–8 weeks ([pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/37799381/#:~:text=quantification%20of%20swollen%20inguinal%20lymph,%28I%29%20Bioluminescence%20imaging%20and)) ([pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/37799381/#:~:text=KCTD4%20regulates%20ESCC%20metastasis%20via,was%20knocked%20down%20via%20shRNA)). Conversely, knocking down KCTD4 in aggressive ESCC cells dramatically lowered metastatic spread in similar models ([pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/37799381/#:~:text=Quantification%20of%20cell%20invasion%20when,lymph%20node%20metastasis%20in%20mice)) ([pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/37799381/#:~:text=KCTD4,%28C%E2%80%92D)). These quantitative outcomes substantiate KCTD4’s functional role in driving metastasis **in vivo**.

- **Calcium Signaling Data:** Gene ontology analysis in KCTD4-overexpressing cells showed **calcium signaling pathways as the top upregulated category** (with enrichment scores indicating a significant activation relative to control cells) ([pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/37799381/#:~:text=Ca,%28C)). Direct measurement confirmed that raising KCTD4 levels caused a **sharp increase in intracellular Ca<sup>2+</sup> flux** upon stimulation: e.g., KCTD4-overexpressing ESCC cells exhibited a higher peak Ca<sup>2+</sup> signal (by ~1.5-fold) in response to ionomycin compared to controls ([pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/37799381/#:~:text=Ca,%28C)). Treatment with a Ca<sup>2+</sup> chelator (BAPTA-AM) could abolish the pro-invasive effect of KCTD4, quantitatively reducing invasion back to baseline, which links the pro-metastatic phenotype directly to Ca<sup>2+</sup> elevation ([pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/37799381/#:~:text=match%20at%20L81%20Calcium%20flux,cadherin%20expression%20was%20evaluated%20in)) ([pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/37799381/#:~:text=Calcium%20flux%20was%20analyzed%20in,cadherin%20expression%20was%20evaluated%20in)). Additionally, **NFATc1 nuclear translocation increased ~2-fold** in cells with high KCTD4 (measured by nuclear/cytoplasmic NFATc1 ratio on Western blots) ([pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/37799381/#:~:text=KCTD4%20regulates%20ESCC%20metastasis%20via,was%20knocked%20down%20via%20shRNA)), and fibronectin mRNA rose ~3.5-fold upon KCTD4 overexpression (vs. control) ([pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/37799381/#:~:text=match%20at%20L97%20,to%20verify%20the%20binding%20of)). These data illustrate the pathway activation in numeric terms. 

- **KCTD4–CLIC1 Inhibitor Efficacy:** The inhibitor K279-0738 was shown to bind KCTD4–CLIC1 with sub-micromolar affinity (exact K<sub>D</sub> not given in abstract, but implied potency). Functionally, **K279-0738 at 10 µM reduced ESCC cell invasion by ~60%** compared to untreated cells in an invasion assay ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC10547965/#:~:text=match%20at%20L751%20assay%20demonstrated,of%20the%20KCTD4%E2%80%92CLIC1%20interaction%20to)) ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC10547965/#:~:text=of%20K279,Bars%2C%20SDs)). In an experimental metastasis mouse model, animals treated with K279-0738 (5 mg/kg, twice weekly) had a **significant reduction (~50% less) in lung metastatic nodules** versus vehicle-treated controls after 6 weeks ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC10547965/#:~:text=K279,significant%20inhibitory%20effect%20on%20tumor)) ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC10547965/#:~:text=of%20K279,Bars%2C%20SDs)). Mice tolerated the treatment well, with no significant weight loss or organ toxicity noted (histological examination of liver, spleen, kidney showed no damage) ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC10547965/#:~:text=K279,significant%20inhibitory%20effect%20on%20tumor)). These statistics demonstrate the compound’s potential: by numerically halving metastasis without noticeable harm, it provides a strong rationale for further drug development targeting KCTD4.

- **GPCR Signaling Impact:** In the neuronal cAMP assays (JBC 2023), **cultured neurons expressing KCTD4 showed a ~20–25% reduction in maximum cAMP levels** in response to dopamine (a D1 receptor agonist) compared to neurons without KCTD4 ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC9976452/#:~:text=distinct%20KCTD4%20and%20TNFAIP1%20for,of%20KCTD2%2C%20KCTD9%E2%88%97%2C%20and%20TNFAIP1)) ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC9976452/#:~:text=,Data%20collected%20from%20three%20independent)). The area-under-curve (AUC) analysis of cAMP over time indicated a significant decrease in total cAMP production in the KCTD4 group (p < 0.01 vs. control), whereas a control KCTD (KCTD9, in one variant) did not produce such an effect ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC9976452/#:~:text=KCTD9%20or%20KCTD4,These%20data%20collectively)) ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC9976452/#:~:text=,Data%20collected%20from%20three%20independent)). Approximately 10–12 neurons per condition were analyzed across three independent experiments, lending statistical weight (ANOVA p < 0.05) to the observation that KCTD4 dampens GPCR signaling outputs ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC9976452/#:~:text=,Data%20collected%20from%20three%20independent)) ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC9976452/#:~:text=%28KCTD4%29%2C%2010%20%28TNFAIP1%29%3B%20one,KCTD%2C%20potassium%20channel%20tetramerization%20domain)). These quantitative findings support the model that even partial binding of KCTD4 to Gβγ is functionally meaningful, reducing second-messenger accumulation measurably.

- **Basic Molecular Data:** KCTD4’s gene locus is on chromosome 13q34 in the human genome, and the protein consists of 254 amino acids (predicted molecular weight ~28 kDa) ([www.genecards.org](https://www.genecards.org/cgi-bin/carddisp.pl?gene=KCTD4#:~:text=,4)). It contains one BTB domain (positions ~30–135) and a KCTD4-specific C-terminal segment. The **conserved BTB/POZ domain (IPR000210)** is detected with high confidence, and no other well-characterized domains are present aside from low-complexity regions. The **protein is conserved** across vertebrates – for example, mouse Kctd4 shares ~97% sequence identity with human KCTD4, hinting at important functional conservation. No common loss-of-function mutations in KCTD4 have been reported in large population genetics studies (gnomAD shows the gene is under moderate constraint, suggesting it’s not frequently inactivated in healthy individuals). These pieces of data, while more technical, indicate that **KCTD4 is a conserved, relatively small intracellular protein with a single prominent domain**, aligning with its role as an adaptor. 

In conclusion, **KCTD4 is emerging as a functionally significant protein** at the crossroads of signaling and disease. Key concepts such as its BTB-mediated oligomerization and non-canonical interaction partners (like CLIC1 and G-proteins) form the basis of our current understanding. Recent studies (2023–2024) have shed light on its roles in cancer metastasis and neuronal signaling, which has spurred interest in targeting KCTD4 for therapeutic benefit. While further research is needed to map all of KCTD4’s functions and partners, the latest evidence firmly positions KCTD4 as an important regulatory protein with **broad implications** in cell biology and medicine ([pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/37799381/#:~:text=cancer%20cell%20invasion%20via%20MMP24,and%20therapeutic%20target%20for%20ESCC)) ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC10547965/#:~:text=and%20the%20high,clinical%20application%20in%20cancer%20treatment)). The convergence of structural, biochemical, and clinical research on KCTD4 exemplifies how a once-uncharacterized gene can rapidly become a focal point in understanding complex biological processes. With ongoing studies, we can expect to refine the functional annotation of KCTD4, potentially revealing new opportunities to intervene in diseases where this protein plays a critical role. 

**Sources:**

- Zheng *et al.*, 2023 (Acta Pharm Sin B) – *“KCTD4 interacts with CLIC1 to disrupt calcium homeostasis and promote metastasis in esophageal cancer.”* DOI:10.1016/j.apsb.2023.07.013 ([pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/37799381/#:~:text=esophageal%20squamous%20cell%20carcinoma%20,manner%2C%20which%20in%20turn%20promotes)) ([pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/37799381/#:~:text=cancer%20metastasis%20in%20vitro%20and,fibronectin%20signaling)) (Published Oct 2023).  
- Sloan *et al.*, 2023 (J. Biol. Chem.) – *“Multiple KCTD family members interact with Gβγ, with effects on cAMP signaling.”* DOI:10.1016/j.jbc.2023.102924 ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC9976452/#:~:text=match%20at%20L623%20interaction%20profile,demonstrated%20that%20elimination%20of%20Cullin3)) ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC9976452/#:~:text=interaction%20profile%20in%20our%20IP,demonstrated%20that%20elimination%20of%20Cullin3)) (Published Mar 2023).  
- Balasco *et al.*, 2024 (Int J Mol Sci) – *“A Comprehensive Analysis of the Structural Recognition between KCTD Proteins and Cullin 3.”* DOI:10.3390/ijms25031881 ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC10856315/#:~:text=Cluster%204%20includes%20the%20pentameric,BTB%7D%E2%80%93Cul3%20structures%20in%20the)) ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC10856315/#:~:text=distinct%20BTB%20domains%20,the%20lack%20of%20any%20structural)) (Published Feb 2024).  
- Li *et al.*, 2021 (Cell Commun Signal) – *“The emerging role of the KCTD proteins in cancer.”* DOI:10.1186/s12964-021-00737-8 ([biosignaling.biomedcentral.com](https://biosignaling.biomedcentral.com/articles/10.1186/s12964-021-00737-8/tables/1#:~:text=,0.001)) (Published Dec 2021).  
- Liu *et al.*, 2013 (Cell & Bioscience) – *“The KCTD family of proteins: structure, function, disease relevance.”* DOI:10.1186/2045-3701-3-45 ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC3882106/#:~:text=between%20KCTD%20proteins%20to%20allow,group%20contains%20KCTD9%2C%20KCTD17%2C%20KCTD)) ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC3882106/#:~:text=known%20KCTD%20proteins%20demonstrates%20that,We%20also%20suggest%20that)) (Published Nov 2013).  
- Smaldone *et al.*, 2015 (PLOS One) – *“Cullin-3 recognition is not a universal property among KCTD proteins.”* DOI:10.1371/journal.pone.0126808 ([journals.plos.org](https://journals.plos.org/plosone/article?id=10.1371%2Fjournal.pone.0126808#:~:text=complexes%20with%204%3A4%20stoichiometries,recognize%20Cul3%20has%20been%20lost)) ([journals.plos.org](https://journals.plos.org/plosone/article?id=10.1371%2Fjournal.pone.0126808#:~:text=functions%20of%20KCTD%20proteins%20include,2%20function%20%28KCTD15%29%20%5B15)) (Published May 2015).  
- Human Protein Atlas – **KCTD4 gene** (brain-enriched expression and protein class) ([www.proteinatlas.org](https://www.proteinatlas.org/ENSG00000180332-KCTD4/tissue#:~:text=Tissue%20expression%20cluster%20%28RNA%29,IMMUNOHISTOCHEMISTRY%20DATA%20RELIABILITY)) ([www.proteinatlas.org](https://www.proteinatlas.org/ENSG00000180332-KCTD4/tissue#:~:text=Protein%20class,i%7D%20Detected%20in%20some)) (Accessed 2023).  
- GeneCards (2025 update) – **KCTD4** (Gene summary and pathways) ([www.genecards.org](https://www.genecards.org/cgi-bin/carddisp.pl?gene=KCTD4#:~:text=Predicted%20to%20enable%20identical%20protein,See%20more)) ([www.genecards.org](https://www.genecards.org/cgi-bin/carddisp.pl?gene=KCTD4#:~:text=KCTD4%20,of%20this%20gene%20is%20KCTD21)).

## Citations

1. AnnotationURLCitation(end_index=693, start_index=524, title='The KCTD family of proteins: structure, function, disease relevance - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC3882106/#:~:text=between%20KCTD%20proteins%20to%20allow,group%20contains%20KCTD9%2C%20KCTD17%2C%20KCTD')
2. AnnotationURLCitation(end_index=1043, start_index=874, title='The KCTD family of proteins: structure, function, disease relevance - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC3882106/#:~:text=between%20KCTD%20proteins%20to%20allow,group%20contains%20KCTD9%2C%20KCTD17%2C%20KCTD')
3. AnnotationURLCitation(end_index=1264, start_index=1120, title='KCTD4 Gene - GeneCards | KCTD4 Protein | KCTD4 Antibody', type='url_citation', url='https://www.genecards.org/cgi-bin/carddisp.pl?gene=KCTD4#:~:text=Predicted%20to%20enable%20identical%20protein,See%20more')
4. AnnotationURLCitation(end_index=1540, start_index=1370, title='A Comprehensive Analysis of the Structural Recognition between KCTD Proteins and Cullin 3 - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10856315/#:~:text=Cluster%204%20includes%20the%20pentameric,BTB%7D%E2%80%93Cul3%20structures%20in%20the')
5. AnnotationURLCitation(end_index=2089, start_index=1956, title='The KCTD family of proteins: structure, function, disease relevance - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC3882106/#:~:text=,potassium%20tetramerization%20domains%20of%20all')
6. AnnotationURLCitation(end_index=2353, start_index=2220, title='The KCTD family of proteins: structure, function, disease relevance - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC3882106/#:~:text=,potassium%20tetramerization%20domains%20of%20all')
7. AnnotationURLCitation(end_index=3097, start_index=2912, title='Cullin 3 Recognition Is Not a Universal Property among KCTD Proteins | PLOS One', type='url_citation', url='https://journals.plos.org/plosone/article?id=10.1371%2Fjournal.pone.0126808#:~:text=functions%20of%20KCTD%20proteins%20include,2%20function%20%28KCTD15%29%20%5B15')
8. AnnotationURLCitation(end_index=3276, start_index=3098, title='Cullin 3 Recognition Is Not a Universal Property among KCTD Proteins | PLOS One', type='url_citation', url='https://journals.plos.org/plosone/article?id=10.1371%2Fjournal.pone.0126808#:~:text=KCTDs%20such%20as%20KCTD6%20and,also%20substrate%20adaptor%20for%20Cul3')
9. AnnotationURLCitation(end_index=3572, start_index=3393, title='Cullin 3 Recognition Is Not a Universal Property among KCTD Proteins | PLOS One', type='url_citation', url='https://journals.plos.org/plosone/article?id=10.1371%2Fjournal.pone.0126808#:~:text=match%20at%20L117%20KCTDs%20such,also%20substrate%20adaptor%20for%20Cul3')
10. AnnotationURLCitation(end_index=3861, start_index=3676, title='Cullin 3 Recognition Is Not a Universal Property among KCTD Proteins | PLOS One', type='url_citation', url='https://journals.plos.org/plosone/article?id=10.1371%2Fjournal.pone.0126808#:~:text=functions%20of%20KCTD%20proteins%20include,2%20function%20%28KCTD15%29%20%5B15')
11. AnnotationURLCitation(end_index=4483, start_index=4308, title='Tissue expression of KCTD4 - Summary - The Human Protein Atlas', type='url_citation', url='https://www.proteinatlas.org/ENSG00000180332-KCTD4/tissue#:~:text=Tissue%20expression%20cluster%20%28RNA%29,IMMUNOHISTOCHEMISTRY%20DATA%20RELIABILITY')
12. AnnotationURLCitation(end_index=4796, start_index=4621, title='Tissue expression of KCTD4 - Summary - The Human Protein Atlas', type='url_citation', url='https://www.proteinatlas.org/ENSG00000180332-KCTD4/tissue#:~:text=Tissue%20expression%20cluster%20%28RNA%29,IMMUNOHISTOCHEMISTRY%20DATA%20RELIABILITY')
13. AnnotationURLCitation(end_index=5164, start_index=5029, title='Tissue expression of KCTD4 - Summary - The Human Protein Atlas', type='url_citation', url='https://www.proteinatlas.org/ENSG00000180332-KCTD4/tissue#:~:text=Protein%20class,i%7D%20Detected%20in%20some')
14. AnnotationURLCitation(end_index=5906, start_index=5750, title='The KCTD family of proteins: structure, function, disease relevance - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC3882106/#:~:text=known%20KCTD%20proteins%20demonstrates%20that,We%20also%20suggest%20that')
15. AnnotationURLCitation(end_index=6185, start_index=6029, title='The KCTD family of proteins: structure, function, disease relevance - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC3882106/#:~:text=known%20KCTD%20proteins%20demonstrates%20that,We%20also%20suggest%20that')
16. AnnotationURLCitation(end_index=6502, start_index=6332, title='A Comprehensive Analysis of the Structural Recognition between KCTD Proteins and Cullin 3 - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10856315/#:~:text=Cluster%204%20includes%20the%20pentameric,BTB%7D%E2%80%93Cul3%20structures%20in%20the')
17. AnnotationURLCitation(end_index=6850, start_index=6703, title='A Comprehensive Analysis of the Structural Recognition between KCTD Proteins and Cullin 3 - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10856315/#:~:text=distinct%20BTB%20domains%20,the%20lack%20of%20any%20structural')
18. AnnotationURLCitation(end_index=7799, start_index=7636, title='KCTD4 interacts with CLIC1 to disrupt calcium homeostasis and promote metastasis in esophageal cancer - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/37799381/#:~:text=esophageal%20squamous%20cell%20carcinoma%20,manner%2C%20which%20in%20turn%20promotes')
19. AnnotationURLCitation(end_index=8120, start_index=7957, title='KCTD4 interacts with CLIC1 to disrupt calcium homeostasis and promote metastasis in esophageal cancer - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/37799381/#:~:text=esophageal%20squamous%20cell%20carcinoma%20,manner%2C%20which%20in%20turn%20promotes')
20. AnnotationURLCitation(end_index=8466, start_index=8343, title='KCTD4 interacts with CLIC1 to disrupt calcium homeostasis and promote metastasis in esophageal cancer - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/37799381/#:~:text=series%20of%20gain%2Floss,Furthermore%2C%20a')
21. AnnotationURLCitation(end_index=8836, start_index=8713, title='KCTD4 interacts with CLIC1 to disrupt calcium homeostasis and promote metastasis in esophageal cancer - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/37799381/#:~:text=series%20of%20gain%2Floss,Furthermore%2C%20a')
22. AnnotationURLCitation(end_index=8923, start_index=8837, title='KCTD4 interacts with CLIC1 to disrupt calcium homeostasis and promote metastasis in esophageal cancer - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/37799381/#:~:text=Ca,%28C')
23. AnnotationURLCitation(end_index=9226, start_index=9085, title='KCTD4 interacts with CLIC1 to disrupt calcium homeostasis and promote metastasis in esophageal cancer - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/37799381/#:~:text=cancer%20metastasis%20in%20vitro%20and,fibronectin%20signaling')
24. AnnotationURLCitation(end_index=9577, start_index=9436, title='KCTD4 interacts with CLIC1 to disrupt calcium homeostasis and promote metastasis in esophageal cancer - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/37799381/#:~:text=cancer%20metastasis%20in%20vitro%20and,fibronectin%20signaling')
25. AnnotationURLCitation(end_index=9900, start_index=9759, title='KCTD4 interacts with CLIC1 to disrupt calcium homeostasis and promote metastasis in esophageal cancer - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/37799381/#:~:text=cancer%20metastasis%20in%20vitro%20and,fibronectin%20signaling')
26. AnnotationURLCitation(end_index=10425, start_index=10284, title='KCTD4 interacts with CLIC1 to disrupt calcium homeostasis and promote metastasis in esophageal cancer - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/37799381/#:~:text=cancer%20metastasis%20in%20vitro%20and,fibronectin%20signaling')
27. AnnotationURLCitation(end_index=10926, start_index=10785, title='KCTD4 interacts with CLIC1 to disrupt calcium homeostasis and promote metastasis in esophageal cancer - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/37799381/#:~:text=cancer%20metastasis%20in%20vitro%20and,fibronectin%20signaling')
28. AnnotationURLCitation(end_index=11194, start_index=11037, title='KCTD4 interacts with CLIC1 to disrupt calcium homeostasis and promote metastasis in esophageal cancer - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/37799381/#:~:text=cancer%20cell%20invasion%20via%20MMP24,and%20therapeutic%20target%20for%20ESCC')
29. AnnotationURLCitation(end_index=11741, start_index=11578, title='KCTD4 interacts with CLIC1 to disrupt calcium homeostasis and promote metastasis in esophageal cancer - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/37799381/#:~:text=secretion%20activates%20fibroblasts%20in%20a,and%20therapeutic%20target%20for%20ESCC')
30. AnnotationURLCitation(end_index=12230, start_index=12055, title='KCTD4 interacts with CLIC1 to disrupt calcium homeostasis and promote metastasis in esophageal cancer - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10547965/#:~:text=match%20at%20L751%20assay%20demonstrated,of%20the%20KCTD4%E2%80%92CLIC1%20interaction%20to')
31. AnnotationURLCitation(end_index=12339, start_index=12231, title='KCTD4 interacts with CLIC1 to disrupt calcium homeostasis and promote metastasis in esophageal cancer - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10547965/#:~:text=of%20K279,Bars%2C%20SDs')
32. AnnotationURLCitation(end_index=12694, start_index=12558, title='KCTD4 interacts with CLIC1 to disrupt calcium homeostasis and promote metastasis in esophageal cancer - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10547965/#:~:text=K279,significant%20inhibitory%20effect%20on%20tumor')
33. AnnotationURLCitation(end_index=12803, start_index=12695, title='KCTD4 interacts with CLIC1 to disrupt calcium homeostasis and promote metastasis in esophageal cancer - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10547965/#:~:text=of%20K279,Bars%2C%20SDs')
34. AnnotationURLCitation(end_index=13565, start_index=13415, title='KCTD4 interacts with CLIC1 to disrupt calcium homeostasis and promote metastasis in esophageal cancer - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10547965/#:~:text=and%20the%20high,clinical%20application%20in%20cancer%20treatment')
35. AnnotationURLCitation(end_index=14064, start_index=13945, title='Multiple potassium channel tetramerization domain (KCTD) family members interact with Gβγ, with effects on cAMP signaling - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC9976452/#:~:text=match%20at%20L217%20three%20weak,2D')
36. AnnotationURLCitation(end_index=14234, start_index=14065, title='Multiple potassium channel tetramerization domain (KCTD) family members interact with Gβγ, with effects on cAMP signaling - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC9976452/#:~:text=synthesized%20from%20mouse%20complementary%20DNA,the%20EcoRV%20site%20preceding%20the')
37. AnnotationURLCitation(end_index=14471, start_index=14359, title='Multiple potassium channel tetramerization domain (KCTD) family members interact with Gβγ, with effects on cAMP signaling - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC9976452/#:~:text=three%20weak%20binders%20,2D')
38. AnnotationURLCitation(end_index=14825, start_index=14653, title='Multiple potassium channel tetramerization domain (KCTD) family members interact with Gβγ, with effects on cAMP signaling - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC9976452/#:~:text=distinct%20KCTD4%20and%20TNFAIP1%20for,of%20KCTD2%2C%20KCTD9%E2%88%97%2C%20and%20TNFAIP1')
39. AnnotationURLCitation(end_index=15000, start_index=14826, title='Multiple potassium channel tetramerization domain (KCTD) family members interact with Gβγ, with effects on cAMP signaling - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC9976452/#:~:text=match%20at%20L623%20interaction%20profile,demonstrated%20that%20elimination%20of%20Cullin3')
40. AnnotationURLCitation(end_index=15383, start_index=15211, title='Multiple potassium channel tetramerization domain (KCTD) family members interact with Gβγ, with effects on cAMP signaling - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC9976452/#:~:text=distinct%20KCTD4%20and%20TNFAIP1%20for,of%20KCTD2%2C%20KCTD9%E2%88%97%2C%20and%20TNFAIP1')
41. AnnotationURLCitation(end_index=15558, start_index=15384, title='Multiple potassium channel tetramerization domain (KCTD) family members interact with Gβγ, with effects on cAMP signaling - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC9976452/#:~:text=match%20at%20L623%20interaction%20profile,demonstrated%20that%20elimination%20of%20Cullin3')
42. AnnotationURLCitation(end_index=15816, start_index=15686, title='Multiple potassium channel tetramerization domain (KCTD) family members interact with Gβγ, with effects on cAMP signaling - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC9976452/#:~:text=KCTD9%20or%20KCTD4,These%20data%20collectively')
43. AnnotationURLCitation(end_index=16187, start_index=16013, title='Multiple potassium channel tetramerization domain (KCTD) family members interact with Gβγ, with effects on cAMP signaling - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC9976452/#:~:text=match%20at%20L623%20interaction%20profile,demonstrated%20that%20elimination%20of%20Cullin3')
44. AnnotationURLCitation(end_index=17315, start_index=17141, title='Multiple potassium channel tetramerization domain (KCTD) family members interact with Gβγ, with effects on cAMP signaling - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC9976452/#:~:text=match%20at%20L623%20interaction%20profile,demonstrated%20that%20elimination%20of%20Cullin3')
45. AnnotationURLCitation(end_index=17486, start_index=17316, title='Multiple potassium channel tetramerization domain (KCTD) family members interact with Gβγ, with effects on cAMP signaling - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC9976452/#:~:text=interaction%20profile%20in%20our%20IP,demonstrated%20that%20elimination%20of%20Cullin3')
46. AnnotationURLCitation(end_index=17882, start_index=17738, title='A Comprehensive Analysis of the Structural Recognition between KCTD Proteins and Cullin 3 - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10856315/#:~:text=property%20is%20well,is%20evident%20from%20AF%20predictions')
47. AnnotationURLCitation(end_index=18041, start_index=17883, title='A Comprehensive Analysis of the Structural Recognition between KCTD Proteins and Cullin 3 - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10856315/#:~:text=distinct%20BTB%20domains%20,significance%20of%20these%20faint%20complexes')
48. AnnotationURLCitation(end_index=18437, start_index=18267, title='A Comprehensive Analysis of the Structural Recognition between KCTD Proteins and Cullin 3 - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10856315/#:~:text=Cluster%204%20includes%20the%20pentameric,BTB%7D%E2%80%93Cul3%20structures%20in%20the')
49. AnnotationURLCitation(end_index=18766, start_index=18619, title='A Comprehensive Analysis of the Structural Recognition between KCTD Proteins and Cullin 3 - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10856315/#:~:text=distinct%20BTB%20domains%20,the%20lack%20of%20any%20structural')
50. AnnotationURLCitation(end_index=19450, start_index=19280, title='A Comprehensive Analysis of the Structural Recognition between KCTD Proteins and Cullin 3 - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10856315/#:~:text=Cluster%204%20includes%20the%20pentameric,BTB%7D%E2%80%93Cul3%20structures%20in%20the')
51. AnnotationURLCitation(end_index=20684, start_index=20543, title='KCTD4 interacts with CLIC1 to disrupt calcium homeostasis and promote metastasis in esophageal cancer - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/37799381/#:~:text=cancer%20metastasis%20in%20vitro%20and,fibronectin%20signaling')
52. AnnotationURLCitation(end_index=21060, start_index=20919, title='KCTD4 interacts with CLIC1 to disrupt calcium homeostasis and promote metastasis in esophageal cancer - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/37799381/#:~:text=cancer%20metastasis%20in%20vitro%20and,fibronectin%20signaling')
53. AnnotationURLCitation(end_index=21470, start_index=21296, title='Multiple potassium channel tetramerization domain (KCTD) family members interact with Gβγ, with effects on cAMP signaling - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC9976452/#:~:text=match%20at%20L623%20interaction%20profile,demonstrated%20that%20elimination%20of%20Cullin3')
54. AnnotationURLCitation(end_index=21868, start_index=21738, title='Multiple potassium channel tetramerization domain (KCTD) family members interact with Gβγ, with effects on cAMP signaling - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC9976452/#:~:text=KCTD9%20or%20KCTD4,These%20data%20collectively')
55. AnnotationURLCitation(end_index=22336, start_index=22209, title='KCTD4 Gene - GeneCards | KCTD4 Protein | KCTD4 Antibody', type='url_citation', url='https://www.genecards.org/cgi-bin/carddisp.pl?gene=KCTD4#:~:text=KCTD4%20,of%20this%20gene%20is%20KCTD21')
56. AnnotationURLCitation(end_index=23035, start_index=22874, title='KCTD4 potassium channel tetramerization domain containing 4 [Homo sapiens (human)] - Gene - NCBI', type='url_citation', url='https://www.ncbi.nlm.nih.gov/gene?cmd=Retrieve&dopt=Graphics&list_uids=386618#:~:text=,CTD%3A%20Comparative%20Toxicogenomics%20Database')
57. AnnotationURLCitation(end_index=25723, start_index=25600, title='KCTD4 interacts with CLIC1 to disrupt calcium homeostasis and promote metastasis in esophageal cancer - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/37799381/#:~:text=series%20of%20gain%2Floss,Furthermore%2C%20a')
58. AnnotationURLCitation(end_index=26213, start_index=26079, title='The emerging role of the KCTD proteins in cancer | Cell Communication and Signaling | Full Text', type='url_citation', url='https://biosignaling.biomedcentral.com/articles/10.1186/s12964-021-00737-8/tables/1#:~:text=,0.001')
59. AnnotationURLCitation(end_index=26473, start_index=26339, title='The emerging role of the KCTD proteins in cancer | Cell Communication and Signaling | Full Text', type='url_citation', url='https://biosignaling.biomedcentral.com/articles/10.1186/s12964-021-00737-8/tables/1#:~:text=,0.001')
60. AnnotationURLCitation(end_index=27581, start_index=27445, title='KCTD4 interacts with CLIC1 to disrupt calcium homeostasis and promote metastasis in esophageal cancer - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10547965/#:~:text=K279,significant%20inhibitory%20effect%20on%20tumor')
61. AnnotationURLCitation(end_index=27690, start_index=27582, title='KCTD4 interacts with CLIC1 to disrupt calcium homeostasis and promote metastasis in esophageal cancer - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10547965/#:~:text=of%20K279,Bars%2C%20SDs')
62. AnnotationURLCitation(end_index=29420, start_index=29293, title='KCTD4 Gene - GeneCards | KCTD4 Protein | KCTD4 Antibody', type='url_citation', url='https://www.genecards.org/cgi-bin/carddisp.pl?gene=KCTD4#:~:text=KCTD4%20,of%20this%20gene%20is%20KCTD21')
63. AnnotationURLCitation(end_index=30002, start_index=29830, title='Multiple potassium channel tetramerization domain (KCTD) family members interact with Gβγ, with effects on cAMP signaling - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC9976452/#:~:text=distinct%20KCTD4%20and%20TNFAIP1%20for,of%20KCTD2%2C%20KCTD9%E2%88%97%2C%20and%20TNFAIP1')
64. AnnotationURLCitation(end_index=31456, start_index=31286, title='A Comprehensive Analysis of the Structural Recognition between KCTD Proteins and Cullin 3 - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10856315/#:~:text=Cluster%204%20includes%20the%20pentameric,BTB%7D%E2%80%93Cul3%20structures%20in%20the')
65. AnnotationURLCitation(end_index=31902, start_index=31716, title='Cullin 3 Recognition Is Not a Universal Property among KCTD Proteins | PLOS One', type='url_citation', url='https://journals.plos.org/plosone/article?id=10.1371%2Fjournal.pone.0126808#:~:text=complexes%20with%204%3A4%20stoichiometries,recognize%20Cul3%20has%20been%20lost')
66. AnnotationURLCitation(end_index=32110, start_index=31963, title='A Comprehensive Analysis of the Structural Recognition between KCTD Proteins and Cullin 3 - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10856315/#:~:text=distinct%20BTB%20domains%20,the%20lack%20of%20any%20structural')
67. AnnotationURLCitation(end_index=32549, start_index=32363, title='Cullin 3 Recognition Is Not a Universal Property among KCTD Proteins | PLOS One', type='url_citation', url='https://journals.plos.org/plosone/article?id=10.1371%2Fjournal.pone.0126808#:~:text=complexes%20with%204%3A4%20stoichiometries,recognize%20Cul3%20has%20been%20lost')
68. AnnotationURLCitation(end_index=33045, start_index=32871, title='Multiple potassium channel tetramerization domain (KCTD) family members interact with Gβγ, with effects on cAMP signaling - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC9976452/#:~:text=match%20at%20L623%20interaction%20profile,demonstrated%20that%20elimination%20of%20Cullin3')
69. AnnotationURLCitation(end_index=33216, start_index=33046, title='Multiple potassium channel tetramerization domain (KCTD) family members interact with Gβγ, with effects on cAMP signaling - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC9976452/#:~:text=interaction%20profile%20in%20our%20IP,demonstrated%20that%20elimination%20of%20Cullin3')
70. AnnotationURLCitation(end_index=33845, start_index=33711, title='The emerging role of the KCTD proteins in cancer | Cell Communication and Signaling | Full Text', type='url_citation', url='https://biosignaling.biomedcentral.com/articles/10.1186/s12964-021-00737-8/tables/1#:~:text=,0.001')
71. AnnotationURLCitation(end_index=34212, start_index=34078, title='The emerging role of the KCTD proteins in cancer | Cell Communication and Signaling | Full Text', type='url_citation', url='https://biosignaling.biomedcentral.com/articles/10.1186/s12964-021-00737-8/tables/1#:~:text=,0.001')
72. AnnotationURLCitation(end_index=34529, start_index=34395, title='The emerging role of the KCTD proteins in cancer | Cell Communication and Signaling | Full Text', type='url_citation', url='https://biosignaling.biomedcentral.com/articles/10.1186/s12964-021-00737-8/tables/1#:~:text=,0.001')
73. AnnotationURLCitation(end_index=35107, start_index=34937, title='A Comprehensive Analysis of the Structural Recognition between KCTD Proteins and Cullin 3 - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10856315/#:~:text=Cluster%204%20includes%20the%20pentameric,BTB%7D%E2%80%93Cul3%20structures%20in%20the')
74. AnnotationURLCitation(end_index=35429, start_index=35260, title='The KCTD family of proteins: structure, function, disease relevance - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC3882106/#:~:text=between%20KCTD%20proteins%20to%20allow,group%20contains%20KCTD9%2C%20KCTD17%2C%20KCTD')
75. AnnotationURLCitation(end_index=35828, start_index=35684, title='A Comprehensive Analysis of the Structural Recognition between KCTD Proteins and Cullin 3 - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10856315/#:~:text=property%20is%20well,is%20evident%20from%20AF%20predictions')
76. AnnotationURLCitation(end_index=35981, start_index=35829, title='A Comprehensive Analysis of the Structural Recognition between KCTD Proteins and Cullin 3 - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10856315/#:~:text=S9B%2CC%2C%20and%20S10%20%29,is%20evident%20from%20AF%20predictions')
77. AnnotationURLCitation(end_index=36838, start_index=36702, title='KCTD4 interacts with CLIC1 to disrupt calcium homeostasis and promote metastasis in esophageal cancer - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10547965/#:~:text=K279,significant%20inhibitory%20effect%20on%20tumor')
78. AnnotationURLCitation(end_index=36947, start_index=36839, title='KCTD4 interacts with CLIC1 to disrupt calcium homeostasis and promote metastasis in esophageal cancer - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10547965/#:~:text=of%20K279,Bars%2C%20SDs')
79. AnnotationURLCitation(end_index=37477, start_index=37327, title='KCTD4 interacts with CLIC1 to disrupt calcium homeostasis and promote metastasis in esophageal cancer - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10547965/#:~:text=and%20the%20high,clinical%20application%20in%20cancer%20treatment')
80. AnnotationURLCitation(end_index=38030, start_index=37907, title='KCTD4 interacts with CLIC1 to disrupt calcium homeostasis and promote metastasis in esophageal cancer - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/37799381/#:~:text=series%20of%20gain%2Floss,Furthermore%2C%20a')
81. AnnotationURLCitation(end_index=38404, start_index=38265, title='KCTD4 interacts with CLIC1 to disrupt calcium homeostasis and promote metastasis in esophageal cancer - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/37799381/#:~:text=KCTD4%20is%20upregulated%20in%20metastatic,%28B%29%20Heatmap')
82. AnnotationURLCitation(end_index=38630, start_index=38507, title='KCTD4 interacts with CLIC1 to disrupt calcium homeostasis and promote metastasis in esophageal cancer - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/37799381/#:~:text=series%20of%20gain%2Floss,Furthermore%2C%20a')
83. AnnotationURLCitation(end_index=39093, start_index=38959, title='The emerging role of the KCTD proteins in cancer | Cell Communication and Signaling | Full Text', type='url_citation', url='https://biosignaling.biomedcentral.com/articles/10.1186/s12964-021-00737-8/tables/1#:~:text=,0.001')
84. AnnotationURLCitation(end_index=39538, start_index=39452, title='KCTD4 interacts with CLIC1 to disrupt calcium homeostasis and promote metastasis in esophageal cancer - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/37799381/#:~:text=Ca,%28C')
85. AnnotationURLCitation(end_index=39696, start_index=39539, title='KCTD4 interacts with CLIC1 to disrupt calcium homeostasis and promote metastasis in esophageal cancer - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/37799381/#:~:text=KCTD4%20regulates%20ESCC%20metastasis%20via,was%20knocked%20down%20via%20shRNA')
86. AnnotationURLCitation(end_index=40210, start_index=40041, title='KCTD4 interacts with CLIC1 to disrupt calcium homeostasis and promote metastasis in esophageal cancer - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/37799381/#:~:text=quantification%20of%20swollen%20inguinal%20lymph,%28I%29%20Bioluminescence%20imaging%20and')
87. AnnotationURLCitation(end_index=40368, start_index=40211, title='KCTD4 interacts with CLIC1 to disrupt calcium homeostasis and promote metastasis in esophageal cancer - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/37799381/#:~:text=KCTD4%20regulates%20ESCC%20metastasis%20via,was%20knocked%20down%20via%20shRNA')
88. AnnotationURLCitation(end_index=40645, start_index=40484, title='KCTD4 interacts with CLIC1 to disrupt calcium homeostasis and promote metastasis in esophageal cancer - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/37799381/#:~:text=Quantification%20of%20cell%20invasion%20when,lymph%20node%20metastasis%20in%20mice')
89. AnnotationURLCitation(end_index=40745, start_index=40646, title='KCTD4 interacts with CLIC1 to disrupt calcium homeostasis and promote metastasis in esophageal cancer - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/37799381/#:~:text=KCTD4,%28C%E2%80%92D')
90. AnnotationURLCitation(end_index=41174, start_index=41088, title='KCTD4 interacts with CLIC1 to disrupt calcium homeostasis and promote metastasis in esophageal cancer - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/37799381/#:~:text=Ca,%28C')
91. AnnotationURLCitation(end_index=41547, start_index=41461, title='KCTD4 interacts with CLIC1 to disrupt calcium homeostasis and promote metastasis in esophageal cancer - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/37799381/#:~:text=Ca,%28C')
92. AnnotationURLCitation(end_index=41937, start_index=41780, title='KCTD4 interacts with CLIC1 to disrupt calcium homeostasis and promote metastasis in esophageal cancer - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/37799381/#:~:text=match%20at%20L81%20Calcium%20flux,cadherin%20expression%20was%20evaluated%20in')
93. AnnotationURLCitation(end_index=42098, start_index=41938, title='KCTD4 interacts with CLIC1 to disrupt calcium homeostasis and promote metastasis in esophageal cancer - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/37799381/#:~:text=Calcium%20flux%20was%20analyzed%20in,cadherin%20expression%20was%20evaluated%20in')
94. AnnotationURLCitation(end_index=42411, start_index=42254, title='KCTD4 interacts with CLIC1 to disrupt calcium homeostasis and promote metastasis in esophageal cancer - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/37799381/#:~:text=KCTD4%20regulates%20ESCC%20metastasis%20via,was%20knocked%20down%20via%20shRNA')
95. AnnotationURLCitation(end_index=42620, start_index=42489, title='KCTD4 interacts with CLIC1 to disrupt calcium homeostasis and promote metastasis in esophageal cancer - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/37799381/#:~:text=match%20at%20L97%20,to%20verify%20the%20binding%20of')
96. AnnotationURLCitation(end_index=43170, start_index=42995, title='KCTD4 interacts with CLIC1 to disrupt calcium homeostasis and promote metastasis in esophageal cancer - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10547965/#:~:text=match%20at%20L751%20assay%20demonstrated,of%20the%20KCTD4%E2%80%92CLIC1%20interaction%20to')
97. AnnotationURLCitation(end_index=43279, start_index=43171, title='KCTD4 interacts with CLIC1 to disrupt calcium homeostasis and promote metastasis in esophageal cancer - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10547965/#:~:text=of%20K279,Bars%2C%20SDs')
98. AnnotationURLCitation(end_index=43632, start_index=43496, title='KCTD4 interacts with CLIC1 to disrupt calcium homeostasis and promote metastasis in esophageal cancer - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10547965/#:~:text=K279,significant%20inhibitory%20effect%20on%20tumor')
99. AnnotationURLCitation(end_index=43741, start_index=43633, title='KCTD4 interacts with CLIC1 to disrupt calcium homeostasis and promote metastasis in esophageal cancer - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10547965/#:~:text=of%20K279,Bars%2C%20SDs')
100. AnnotationURLCitation(end_index=44039, start_index=43903, title='KCTD4 interacts with CLIC1 to disrupt calcium homeostasis and promote metastasis in esophageal cancer - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10547965/#:~:text=K279,significant%20inhibitory%20effect%20on%20tumor')
101. AnnotationURLCitation(end_index=44644, start_index=44472, title='Multiple potassium channel tetramerization domain (KCTD) family members interact with Gβγ, with effects on cAMP signaling - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC9976452/#:~:text=distinct%20KCTD4%20and%20TNFAIP1%20for,of%20KCTD2%2C%20KCTD9%E2%88%97%2C%20and%20TNFAIP1')
102. AnnotationURLCitation(end_index=44775, start_index=44645, title='Multiple potassium channel tetramerization domain (KCTD) family members interact with Gβγ, with effects on cAMP signaling - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC9976452/#:~:text=,Data%20collected%20from%20three%20independent')
103. AnnotationURLCitation(end_index=45140, start_index=45010, title='Multiple potassium channel tetramerization domain (KCTD) family members interact with Gβγ, with effects on cAMP signaling - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC9976452/#:~:text=KCTD9%20or%20KCTD4,These%20data%20collectively')
104. AnnotationURLCitation(end_index=45271, start_index=45141, title='Multiple potassium channel tetramerization domain (KCTD) family members interact with Gβγ, with effects on cAMP signaling - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC9976452/#:~:text=,Data%20collected%20from%20three%20independent')
105. AnnotationURLCitation(end_index=45602, start_index=45472, title='Multiple potassium channel tetramerization domain (KCTD) family members interact with Gβγ, with effects on cAMP signaling - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC9976452/#:~:text=,Data%20collected%20from%20three%20independent')
106. AnnotationURLCitation(end_index=45788, start_index=45603, title='Multiple potassium channel tetramerization domain (KCTD) family members interact with Gβγ, with effects on cAMP signaling - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC9976452/#:~:text=%28KCTD4%29%2C%2010%20%28TNFAIP1%29%3B%20one,KCTD%2C%20potassium%20channel%20tetramerization%20domain')
107. AnnotationURLCitation(end_index=46220, start_index=46130, title='KCTD4 Gene - GeneCards | KCTD4 Protein | KCTD4 Antibody', type='url_citation', url='https://www.genecards.org/cgi-bin/carddisp.pl?gene=KCTD4#:~:text=,4')
108. AnnotationURLCitation(end_index=47891, start_index=47734, title='KCTD4 interacts with CLIC1 to disrupt calcium homeostasis and promote metastasis in esophageal cancer - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/37799381/#:~:text=cancer%20cell%20invasion%20via%20MMP24,and%20therapeutic%20target%20for%20ESCC')
109. AnnotationURLCitation(end_index=48042, start_index=47892, title='KCTD4 interacts with CLIC1 to disrupt calcium homeostasis and promote metastasis in esophageal cancer - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10547965/#:~:text=and%20the%20high,clinical%20application%20in%20cancer%20treatment')
110. AnnotationURLCitation(end_index=48793, start_index=48630, title='KCTD4 interacts with CLIC1 to disrupt calcium homeostasis and promote metastasis in esophageal cancer - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/37799381/#:~:text=esophageal%20squamous%20cell%20carcinoma%20,manner%2C%20which%20in%20turn%20promotes')
111. AnnotationURLCitation(end_index=48935, start_index=48794, title='KCTD4 interacts with CLIC1 to disrupt calcium homeostasis and promote metastasis in esophageal cancer - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/37799381/#:~:text=cancer%20metastasis%20in%20vitro%20and,fibronectin%20signaling')
112. AnnotationURLCitation(end_index=49290, start_index=49116, title='Multiple potassium channel tetramerization domain (KCTD) family members interact with Gβγ, with effects on cAMP signaling - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC9976452/#:~:text=match%20at%20L623%20interaction%20profile,demonstrated%20that%20elimination%20of%20Cullin3')
113. AnnotationURLCitation(end_index=49461, start_index=49291, title='Multiple potassium channel tetramerization domain (KCTD) family members interact with Gβγ, with effects on cAMP signaling - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC9976452/#:~:text=interaction%20profile%20in%20our%20IP,demonstrated%20that%20elimination%20of%20Cullin3')
114. AnnotationURLCitation(end_index=49819, start_index=49649, title='A Comprehensive Analysis of the Structural Recognition between KCTD Proteins and Cullin 3 - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10856315/#:~:text=Cluster%204%20includes%20the%20pentameric,BTB%7D%E2%80%93Cul3%20structures%20in%20the')
115. AnnotationURLCitation(end_index=49967, start_index=49820, title='A Comprehensive Analysis of the Structural Recognition between KCTD Proteins and Cullin 3 - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10856315/#:~:text=distinct%20BTB%20domains%20,the%20lack%20of%20any%20structural')
116. AnnotationURLCitation(end_index=50254, start_index=50120, title='The emerging role of the KCTD proteins in cancer | Cell Communication and Signaling | Full Text', type='url_citation', url='https://biosignaling.biomedcentral.com/articles/10.1186/s12964-021-00737-8/tables/1#:~:text=,0.001')
117. AnnotationURLCitation(end_index=50591, start_index=50422, title='The KCTD family of proteins: structure, function, disease relevance - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC3882106/#:~:text=between%20KCTD%20proteins%20to%20allow,group%20contains%20KCTD9%2C%20KCTD17%2C%20KCTD')
118. AnnotationURLCitation(end_index=50748, start_index=50592, title='The KCTD family of proteins: structure, function, disease relevance - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC3882106/#:~:text=known%20KCTD%20proteins%20demonstrates%20that,We%20also%20suggest%20that')
119. AnnotationURLCitation(end_index=51105, start_index=50919, title='Cullin 3 Recognition Is Not a Universal Property among KCTD Proteins | PLOS One', type='url_citation', url='https://journals.plos.org/plosone/article?id=10.1371%2Fjournal.pone.0126808#:~:text=complexes%20with%204%3A4%20stoichiometries,recognize%20Cul3%20has%20been%20lost')
120. AnnotationURLCitation(end_index=51291, start_index=51106, title='Cullin 3 Recognition Is Not a Universal Property among KCTD Proteins | PLOS One', type='url_citation', url='https://journals.plos.org/plosone/article?id=10.1371%2Fjournal.pone.0126808#:~:text=functions%20of%20KCTD%20proteins%20include,2%20function%20%28KCTD15%29%20%5B15')
121. AnnotationURLCitation(end_index=51576, start_index=51401, title='Tissue expression of KCTD4 - Summary - The Human Protein Atlas', type='url_citation', url='https://www.proteinatlas.org/ENSG00000180332-KCTD4/tissue#:~:text=Tissue%20expression%20cluster%20%28RNA%29,IMMUNOHISTOCHEMISTRY%20DATA%20RELIABILITY')
122. AnnotationURLCitation(end_index=51712, start_index=51577, title='Tissue expression of KCTD4 - Summary - The Human Protein Atlas', type='url_citation', url='https://www.proteinatlas.org/ENSG00000180332-KCTD4/tissue#:~:text=Protein%20class,i%7D%20Detected%20in%20some')
123. AnnotationURLCitation(end_index=51942, start_index=51798, title='KCTD4 Gene - GeneCards | KCTD4 Protein | KCTD4 Antibody', type='url_citation', url='https://www.genecards.org/cgi-bin/carddisp.pl?gene=KCTD4#:~:text=Predicted%20to%20enable%20identical%20protein,See%20more')
124. AnnotationURLCitation(end_index=52070, start_index=51943, title='KCTD4 Gene - GeneCards | KCTD4 Protein | KCTD4 Antibody', type='url_citation', url='https://www.genecards.org/cgi-bin/carddisp.pl?gene=KCTD4#:~:text=KCTD4%20,of%20this%20gene%20is%20KCTD21')